Vor Bio adds RA Capital and Forbion partners to board Dec 23, 2025 04:01PM
Vor Bio Appoints RA Capital’s Andrew Levin, M.D., Ph.D., and Forbion’s Wouter Joustra to Board of Directors Dec 23, 2025 04:01PM
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P. Dec 18, 2025 06:31PM
Vor Bio raises $150 million in private placement for drug development Dec 15, 2025 08:01AM
Vor Bio Announces $150 Million Private Placement Dec 15, 2025 08:00AM


Nov 14, 2025 06:13PM Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Oct 30, 2025 06:42PM Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Oct 27, 2025 08:07PM Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Oct 20, 2025 07:02PM Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Sep 19, 2025 04:54PM Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 27, 2025 04:16PM Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Jun 26, 2025 02:00AM PureTech Founded Entity Vor Bio Announces Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset and $175 Million Private Placement
Jun 25, 2025 04:50PM Vor Biopharma (VOR) Announces $175 Million Private Placement
Jun 25, 2025 04:50PM Vor Bio Announces $175 Million Private Placement
Mar 20, 2025 04:05PM Vor Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Company Update
Dec 30, 2024 06:51PM Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 27, 2024 09:01AM Vor Biopharma (VOR) Announces $55.6M Placement
Dec 27, 2024 09:00AM Vor Bio Announces $55.6 Million Private Placement
Aug 11, 2023 05:06PM Form SC 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 9, 2022 04:31PM Form SC 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Dec 7, 2022 07:45AM Vor Biopharma (VOR) Prices Underwritten Offering of Common Stock and Concurrent Private Placement for Aggregate Proceeds of $115.8 Million
Dec 7, 2022 07:45AM Vor Bio Prices Underwritten Offering of Common Stock and Concurrent Private Placement for Aggregate Proceeds of $115.8 Million
Nov 14, 2022 04:47PM Form SC 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 19, 2021 04:31PM Form SC 13D Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 4, 2021 09:47PM Form 3 Vor Biopharma Inc. For: Feb 04 Filed by: RA CAPITAL MANAGEMENT, L.P.